Home \ Outreach \


Evaluation of the antibody production of a trial on VLP vaccines for bluetongue 1 and 4 serotypes

Conference in VIII Congreso de Ciencias Veterinarias y Biomedicas

April 27th, 2009

Perez de Diego AC., Espinosa L. and Sanchez-Vizcaino JM.

The main purpose of this study was to evaluate by a competitive ELISA test the VP7
antibodies in response to VLPs vaccines for bluetongue serotypes 1 & 1+4, and after the virus
challenge, to assess the humoral immune response produced by these VLPs. The three
vaccinated groups showed positive results 35 days after the vaccination. However, in non
vaccinated animals antibodies were not detected before day 10 post virus challenge.
The presence of antibodies in vaccinated animals implies that VLP Vaccines are able to
stimulate a humoral response




Participants:

Universidad ComplutenseServicio de Inmunología Viral y Medicina Preventiva (SUAT). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM).

Universidad ComplutenseDepartamento de Sanidad Animal. Facultad de Veterinaria. Universidad Complutense (UCM).


Go to publication web
Publication: Evaluation of the antibody production of a trial on VLP vaccines for bluetongue 1 and 4 serotypes





publiDB

VIII Congreso de Ciencias Veterinarias y Biomedicas



TITLE: Valoracion de la produccion de anticuerpos en un ensayo de vacunas VLP frente a los serotipos 1 y 4 de la lengua azul


TYPE: Oral communication


AUTHORS: Perez de Diego AC., Espinosa L. and Sanchez-Vizcaino JM.


VISAVET PARTICIPANTS


José Manuel Sánchez-Vizcaíno Rodríguez

DATE: April 27th, 2009


CITE THIS COMMUNICATION:

Perez de Diego AC., Espinosa L. and Sanchez-Vizcaino JM. Evaluation of the antibody production of a trial on VLP vaccines for bluetongue 1 and 4 serotypes. VIII Congreso de Ciencias Veterinarias y Biomedicas, Facultad de Veterinaria. UCM, April 27th, 2009. (Oral communication)


UNITS: